HKEx Stock Code: 01093English|繁體|简体

In 2017 Interim Results

  • Sales of approximately HK$7,202 million, representing a 17.2% growth (or a 23.2% growth on a constant currency basis) year-on-year.
  • Profit attributable to shareholders of approximately HK$1,313 million, representing a 27.1% growth (or a 33.6% growth on a constant currency basis) year-on-year.

Highlight - 2017 Interim

Revenue
HK$7,202 mn
Attributable profit
HK$1,313 mn
Basic earnings per share
HK21.69 cents

Corporate Governance

Corporate Governance

Financial Calendar

NOV
15
NOV
15
AUG
22
AUG
22
May
25
May
25
May
25
Mar
20
Mar
20

Financial Reports

Financial Reports

Financial Summary

Financial Summary

IR Contacts

Address : Suite 3206, 32/F, Central Plaza,
18 Harbour Road, Wanchai, Hong Kong
Tel : (852) 2500 3144
Fax : (852) 2802 4552
E-mail : ir@cspc.hk
© Copyright 2017 CSPC Pharmaceutical Group Limited. All Rights Reserved.